Genomics Bioscience & Technology Co Stock

Genomics Bioscience & Technology Co Forward P/E

The Forward P/E Ratio of Genomics Bioscience & Technology Co (4195.TWO) as of Aug 10, 2026 is -45.39. In the previous year, Forward P/E Ratio was -8.02 — a change of 465.85% (lower).

Forward P/E

-45.39

YoY

465.85%

Last updated:

Forward P/E Ratio of Genomics Bioscience & Technology Co is 2026 -45.39 . Forward P/E Ratio of Genomics Bioscience & Technology Co was 2025 -8.02 . It decreases by 465.85% lower compared to the previous year.
Access this data via the Eulerpool API

Genomics Bioscience & Technology Co Stock analysis

What does Genomics Bioscience & Technology Co do? Genomics Bioscience & Technology Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Genomics Bioscience & Technology Co stock

Forward P/E Ratio of Genomics Bioscience & Technology Co is -45.39 in 2026.

Forward P/E Ratio of Genomics Bioscience & Technology Co changed from -8.02 to -45.39, representing a 465.85% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Forward P/E Ratio Genomics Bioscience & Technology Co since 2006 – with annual values, charts, and detailed analysis.

The Forward P/E uses estimated future earnings to value a stock. A lower forward P/E relative to the trailing P/E suggests analysts expect earnings growth.

To evaluate Forward P/E Ratio's, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Forward P/E Ratio.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Forward P/E Ratio's Genomics Bioscience & Technology Co with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

Valuation — Genomics Bioscience & Technology Co

All Key Metrics — Genomics Bioscience & Technology Co